Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up

Documenta Ophthalmologica

Volumn 120, Issue 3, 2010, Pages 251-264

  Salu, Paul ^a   Uvijls, André ^a   Van Den Brande, Pierre ^a   Leroy, Bart P ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Central visual field; Colour vision; Contrast sensitivity; Electrophysiological tests: EOG, ERG, mfERG; Hydroxychloroquine retinopathy

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; ARTICLE; B WAVE; CASE REPORT; COLOR VISION; CONTRAST SENSITIVITY; DISEASE COURSE; DISEASE SEVERITY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; NIGHT VISION; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA MACULOPATHY; RETINOPATHY; SCOTOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT WITHDRAWAL; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

ANTIRHEUMATIC AGENTS; CONTRAST SENSITIVITY; DISEASE PROGRESSION; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RETINA; RETINAL DISEASES; SCOTOMA; VISUAL ACUITY; VISUAL FIELDS;

EID: 77953232226     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-010-9220-7     Document Type: Article

References (34)

1. A Cambiaggi 1957 Unusual ocular lesions in a case of systemic lupus erythematosus Arch Ophthalmol 57 451 453 1:STN:280:DyaG2s%2Fls1GltA%3D%3D
2. HE Hobbs A Sorsby A Freedman 1959 Retinopathy following chloroquine therapy Lancet 2 478 480 10.1016/S0140-6736(59)90604-X 1:STN:280: DyaF3c7lsVOmtw%3D%3D 14402143
3. RV Shearer EL Dubois 1967 Ocular changes induced by long-term hydroxychloroquine (Plaquenil) therapy Am J Ophthalmol 64 245 252 1:STN:280:DyaF2s3hsFaiuw%3D%3D 6036279
4. AH Mackenzie 1983 Dose refinements in long-term therapy of rheumatoïd arthritis with antimalarials Am J Med 74 40 45 10.1016/0002-9343(83)91269-X
5. MF Marmor RE Carr M Easterbook AA Farjo WF Mieler 2002 Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by The American Academy of Ophthalmology Ophthalmology 109 1377 1382 10.1016/S0161-6420(02)01168-5 12093666 (Pubitemid 34700934)
6. R Tzekov 2005 Ocular toxicity due to chloroquine and hydroxy-chloroquine: electrophysiological and visual function correlates Doc Ophthalmol 110 111 120 10.1007/s10633-005-7349-6 16249962 (Pubitemid 43055086)
7. TR Brinkley EL Dubois 1979 Long term course of chloroquine retinopathy after cessation of medication Am J Ophthalmol 88 1 11 463998
8. M Easterbook 1992 Long term courses of antimalarial maculopathy after cessation of treatment Can J Ophthalmol 27 237 239
9. LC Wei SN Chen CL Ho YH Kuo JD Ho 2001 Progressive of hydroxychloroquine retinopathy, after discontinuation of therapy: case report Chang Gung Med J 24 329 334 1:STN:280:DC%2BD3MvjtlSjsw%3D%3D 11480331
10. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2008 update) ISCEV standard for full-field clinical electroretinography. Doc Ophthalmol 118:69-77
11. DC Hood M Bach M Brigell D Keating M Kondo JS Lyons AM Palmowski-Wolfe 2008 ISCEV guidelines for clinical multifocal electroretinography Doc Ophthalmol 116 1 11 10.1007/s10633-007-9089-2 17972125
12. M Brown MF Marmor ZE Vaegan M Brigell M Bach 2006 ISCEV standard for clinical electro-oculography (EOG) 2006 Doc Ophthalmol 113 205 212 10.1007/s10633-006-9030-0 17109157 (Pubitemid 44835005)
13. U Kellner M Kraus MH Foerster 2000 Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction Graefe's Arch Clin Exp Ophthalmol 238 94 97 10.1007/s004170050016 1:STN:280:DC%2BD3c7jtVSmsA%3D%3D
14. JS Lyons M Severns 2007 Detection of early hydroxychloroquine retinal toxicity enhanced by long ratio analysis of multifocal electroretinography Am J Ophthalmol 143 801 809 10.1016/j.ajo.2006.12.042 1:CAS:528:DC%2BD2sXksVOqsrk%3D 17336914 (Pubitemid 46601379)
15. JS Lyons ML Severns 2009 Using multifocal ERG ring ratios to detect and follow plaquenil toxicity: a review Doc Ophthalmol 118 29 36 10.1007/s10633-008-9130-0 18465156
16. Pokorny J, Smith VC, Verriest G, Pinckers AJLG (1979) Congenital and acquired color vision defects. New York-London-Toronto-Sydney-San Francisco, Grune and Stratton 334-336
17. Jaeger W, Krastel H (1985) Colour vision deficiencies caused by pharmacotherapy. In: Verriest G (ed) Colour vision deficiencies VIII. In: Proceedings 8th symposium of the IRGCVD, Avignon 1985. M. Nyhoff/Dr. W. Junk Publishers 1987; Doc. Ophthalmol. Proc. Ser. 46:37-52
18. J François G Verriest 1957 Les dyschromatopsies acquises Ann Ocul (Paris) 190 713 746
19. G Verriest 1964 Les déficiences acquises de la discrimination chromatique Mém Acad R Méd Belg II 5 35 327
20. F Sucs A Uvijls 1992 Contrast sensitivity in retinitis pigmentosa at different luminance levels Clin Vis Sci 2 147 151
21. NF Shroyer RA Lewis JR Lupski 2001 Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to stargardt disease? Am J Ophthalmol 131 761 766 10.1016/S0002-9394(01)00838-8 1:CAS:528:DC%2BD3MXjvFSitL8%3D 11384574 (Pubitemid 32522647)
22. M Easterbrook 1988 Ocular effects and safety of antimalarial agents Am J Med 85 23 29 10.1016/0002-9343(88)90358-0 1:STN:280:DyaL1M%2Fitlajug%3D%3D 3177429
23. EB Arden MR Frojas 1962 Electrophysiological abnormalities in pigmentary degeneration of the retina Arch Ophthalmol 68 105 125
24. AS Neubauer K Samari-Kermani U Schaller U Welge-lussen G Rudolph T Berninger 2003 Detecting chloroquine retinopathy: electro-oculogram versus colour vision Br J Ophthalmol 87 902 908 10.1136/bjo.87.7.902 1:STN:280:DC%2BD3s3osFemtg%3D%3D 12812896 (Pubitemid 36765260)
25. R Halfeld-Furtado JO Oliveira Maia WY Tahahashi 2007 Electrophysiologic findings in chloroquine maculopathy Doc Ophthalmol 115 117 119 10.1007/s10633-007-9060-2 (Pubitemid 47412805)
26. P Henkind RE Carr IM Siegel 1964 Early chloroquine retinopathy: clinical and functional findings Arch Ophthalmol 71 157 165 1:STN:280: DyaF2c%2FkslSmsw%3D%3D 14089382
27. U Nylander 1967 Ocular damage in chloroquine therapy Acta Ophthalmol Suppl 92 1 71
28. I Ingster-Moati QE Bui M Crocket 2006 Intoxication rétinienne sévère aux anti-paludiens de synthese J Fr Ophtalmol 29 641 650
29. TY Lai WM Chan H Li RY Lai DS Lam 2005 Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy Am J Ophthalmol 140 794 807 10.1016/j.ajo.2005.05.046 16310457 (Pubitemid 41727671)
30. TY Lai JN Ngai WM Chan DS Lam 2006 Visual field and multifocal electroretinography and their correlations in patients with hydroxychloroquine therapy Doc Ophthalmol 112 177 187 10.1007/s10633-006-9006-0 16804707 (Pubitemid 44295792)
31. P Grützner 1969 Acquired color vision defects secondary to retinal drug toxicity Ophthalmologica 158 592 604 5307973
32. BL Vu M Easterbrook JK Hovis 1999 Detection of color vision defects in chloroquine retinopathy Ophthalmology 106 1799 1803 10.1016/S0161-6420(99)90338- X 1:STN:280:DyaK1MvhtlGlsQ%3D%3D 10485553
33. SA Bishara N Matamoros 1989 Evaluation of several tests in screening for chloroquine maculopathy Eye 3 777 782 2630362
34. GJ Mahon HR Anderson TA Gardiner 2004 Chloroquine causes lysosomal dysfunction in neural retina and RPE. Implications for retinopathy Curr Eye Res 28 274 284 10.1076/ceyr.28.4.277.27835 (Pubitemid 38491321)